Sugi Predict

Sugi Predict / Compounds / SCHEMBL7182845

SCHEMBL7182845

SCHEMBL7182845

CCCCC(CC)C[P](=O)c1ccccc1C(=O)c1c(C)cc(C)cc1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.43
▸ CA2 P00918 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ LMNA P02545 2/20 0.40
▸ PRSS1 P07477 1/20 0.39
▸ PRSS2 P07478 1/20 0.39
▸ PRSS3 P35030 1/20 0.39
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ TSHR P16473 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ CNR2 P34972 7/20 0.34
▸ CNR1 P21554 5/20 0.34
▸ HPGD P15428 2/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ MCOLN3 Q8TDD5 1/20 0.34
▸ BCL2L1 Q07817 1/20 0.34
▸ PYGL P06737 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7185614 0.91 ALDH1A1 (0.44) ALDH1A1CA2CYP3A4LMNAPRSS1
SCHEMBL7174994 0.89 ALDH1A1 (0.44) ALDH1A1CA2CYP3A4LMNAPRSS1
SCHEMBL7181145 0.83 ALDH1A1 (0.43) ALDH1A1CA2CYP3A4LMNAPRSS1
SCHEMBL7180883 0.83 ALDH1A1 (0.44) ALDH1A1CA2CYP3A4LMNAPRSS1
SCHEMBL7182225 0.81 CA2 (0.44) ALDH1A1CA2CYP3A4LMNAPRSS1
SCHEMBL7180484 0.81 MEN1 (0.39) ALDH1A1CYP3A4LMNAMEN1KMT2A
SCHEMBL7179788 0.81 HPGD (0.43) ALDH1A1LMNAMEN1KMT2ATSHR
SCHEMBL7189807 0.81 CA2 (0.41) ALDH1A1CA2CYP3A4LMNAPRSS1
SCHEMBL1138268 0.79 KMT2A (0.43) ALDH1A1LMNAMEN1KMT2ATSHR
SCHEMBL7189206 0.77 KMT2A (0.40) ALDH1A1LMNAMEN1KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6579663-B2 Chemical intermediates such as lithium 2,6-dimethylbenzoyl phenylphosphine for preparation of acylphosphines, acylphosphine oxides or acylphosphine sulfides CIBA SPECIALTY CHEMICALS CORPORATION 2003-06-17 — — US disclosed
US-20020107413-A1 Organometallic monoacylarylphosphines WOLF JEAN-PIERRE (CH) 2002-08-08 — — US disclosed
US-6399805-B2 SUCH AS LITHIUM 2,6-DIMETHYLBENZOYLPHENYLPHOSPHINE, USE AS PHOTOINITIATORS IN PHOTOCURABLE COMPOSITIONS SUCH AS FOR PHOTOGRAPHIC PRODUCTION OF RELIEF IMAGES CIBA SPECIALTY CHEMICALS CORPORATION 2002-06-04 — — US disclosed
US-20010031898-A1 Organometallic monoacylarylphosphines CIBA SPECIALTY CHEMICALS CORP. 2001-10-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020107413-A1 Organometallic monoacylarylphosphines CBR1, NAF1, DHCR24 ALDH1A1 3416/4885CA2 2297/4885CYP3A4 1652/4885
US-20010031898-A1 Organometallic monoacylarylphosphines NAF1, DHCR24, CBR1 ALDH1A1 3984/4885CA2 2346/4885CYP3A4 1881/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.